DCPH Deciphera Pharmaceuticals Inc
3,200
$25.46
$0.01
(0.04%)
| Watchers | 3,200 |
| 52-Wk Low | $9.90 |
| 52-Wk High | $25.55 |
| Market Cap | $2.2B |
| Volume | 1.15M |
| 52-Wk High | $25.55 |
| 52-Wk Low | $9.90 |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPHPR Newswire • 4 days ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPH SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPH PR Newswire NEW YORK, May 13, 2024 NEW YORK, May 13...
Share to Feed
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, IONM, DPSI SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, IONM, DPSI PR Newswire NEW YORK, May 10, 2024 NEW YORK, May...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK PR Newswire NEW YORK, May 2, 2024 NEW...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Deciphera Pharmaceuticals, Inc. (NasdaqGS...
Latest Ratings for DCPH
DateFirmActionFromTo Feb 2022BarclaysDowngradesEqual-WeightUnderweight Dec 2021HC Wainwright & Co.MaintainsBuy Nov 2021Truist SecuritiesDowngradesBuyHold
View More...
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals PR Newswire OSAKA, Japan, April 30, 2024 OSAKA...
INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, HCP SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, HCP PR Newswire NEW YORK, April 29, 2024 NEW YORK, April...
read more...
Shareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co. Shareholder Alert: Ademi LLP investigates...